Anti-UBA7 / Ubiquitin like modifier activating enzyme 7 / Ube1L, clone 31U08

Item number Size Datasheet Manual SDS Delivery time Quantity Price
NSJ-FY12672 100 µl - -

3 - 10 business days*

790.00€
 
Rabbit IgG in phosphate buffered saline, pH 7.4, 150mM NaCl, 0.02% sodium azide and 50% glycerol,... more
Product information "Anti-UBA7 / Ubiquitin like modifier activating enzyme 7 / Ube1L, clone 31U08"
Rabbit IgG in phosphate buffered saline, pH 7.4, 150mM NaCl, 0.02% sodium azide and 50% glycerol, 0.4-0.5mg/ml BSA. UBA7 antibody detects ubiquitin like modifier activating enzyme 7, an E1 enzyme encoded by the UBA7 gene. UBA7 catalyzes the first step in the ISGylation pathway, activating the ubiquitin like modifier ISG15. This modification resembles ubiquitination but involves the conjugation of ISG15 to target proteins, regulating antiviral responses, immune signaling, and protein stability. By activating ISG15, UBA7 plays a central role in interferon stimulated gene expression and innate immunity.UBA7 antibody is widely applied in immunology, virology, and cancer biology. UBA7 is induced by type I interferons and mediates host defense against viral infection. ISGylation of viral and host proteins disrupts replication cycles and enhances antiviral resistance. By detecting UBA7, researchers can investigate how interferon pathways regulate protein modification and innate immunity. Western blot assays detect UBA7 protein in interferon treated cells, while immunohistochemistry maps its expression in immune tissues. Immunofluorescence highlights cytoplasmic and nuclear localization, consistent with its role in protein conjugation. These applications make UBA7 antibody a versatile tool for studying antiviral responses and immune regulation.Beyond virology, UBA7 contributes to tumor suppression. Loss of UBA7 expression has been linked to lung cancer and leukemia, where reduced ISGylation disrupts normal cell regulation. UBA7 also interacts with ubiquitin conjugating enzymes, linking ISGylation to broader protein quality control mechanisms. By applying UBA7 antibody, scientists can evaluate how ubiquitin like modifications influence cancer biology and immune defense.UBA7 antibody from NSJ Bioreagents provides dependable specificity for analyzing ISGylation pathways. Its strong performance across applications supports both basic and translational research into immune signaling, antiviral defense, and cancer suppression.
Keywords: Anti-D8, Anti-UBA7, Anti-Ubiquitin-activating enzyme E1 homolog, Anti-Ubiquitin-like modifier-activating enzyme 7, UBA7 Antibody / Ubiquitin like modifier activating enzyme 7 / Ube1L
Supplier: NSJ Bioreagents
Supplier-Nr: FY12672

Properties

Application: WB, IHC, FC
Antibody Type: Monoclonal
Clone: 31U08
Conjugate: No
Host: Rabbit
Species reactivity: human, mouse, rat
Immunogen: A synthesized peptide derived from human Ube1L / UBA7
Format: Purified

Handling & Safety

Storage: -20°C
Shipping: -20°C (International: -20°C)
Caution
Our products are for laboratory research use only: Not for administration to humans!
You will get a certificate here
or to request a certificate of analysis.
Read, write and discuss reviews... more
Customer review for "Anti-UBA7 / Ubiquitin like modifier activating enzyme 7 / Ube1L, clone 31U08"
Write a review
or to review a product.
Viewed